The increasing prevalence of shortages around the EU is a key concern for Affordable Medicines Europe. Parallel trade is occasionally mentioned as one of the causes. One such myth is the unidirectional travel of medicines from low-income to high-income countries. In this study, we update the facts around the parallel trade flows in Europe, first documented in 2018 and then in 2020. This year, we have gathered data for both 2022 and 2023. 2022 marked the first year when the UK was no longer part of the EU Single Market.